证券代码：002385 证券简称：大北农 公告编号：2025-057 北京大北农科技集团股份有限公司 2025 年第三次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1.本次股东大会未出现否决提案的情形； 2.本次股东大会不涉及变更以往股东大会已通过的决议。 ②通过互联网投票系统（http://wltp.cninfo.com.cn）投票的具体时间为：2025 年 6 月 16 日上午 09:15 至下午 15:00 期间的任意时间。 3.会议召开方式：采取现场投票与网络投票相结合的方式 2.现场会议召开地点：北京市海淀区澄湾街 19 号院大北农凤凰国际创新园 行政楼 104 会议室 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间 (1)现场会议召开时间：2025 年 6 月 16 日（星期一）下午 14：30 开始 (2)网络投票起止时间： ①通过深圳证券交易所（以下简称"深交所"）交易系统进行网络投票的具 体时间为：2025 年 6 月 16 日 9:15—9:25，9:30—11:30 和 13:00—15 ...

致：北京大北农科技集团股份有限公司 北京大北农科技集团股份有限公司（以下简称"公司"）2025 年第三次临时 股东大会（以下简称"本次股东大会"）采取现场投票与网络投票相结合的方式， 现场会议于 2025 年 6 月 16 日 14:30 在北京市海淀区澄湾街 19 号院大北农凤凰 国际创新园行政楼 104 会议室召开。北京市天元律师事务所（以下简称"本所"） 接受公司聘任，指派本所律师参加本次股东大会现场会议，并根据《中华人民共 和国公司法》、《中华人民共和国证券法》（以下简称"《证券法》"）、《上 市公司股东会规则》（以下简称"《股东会规则》"）以及《北京大北农科技集 团股份有限公司章程》（以下简称"《公司章程》"）等有关规定，就本次股东 大会的召集、召开程序、出席现场会议人员的资格、召集人资格、会议表决程序 及表决结果等事项出具本法律意见。 为出具本法律意见，本所律师审查了《北京大北农科技集团股份有限公司第 六届董事会第三十一次（临时）会议决议公告》《北京大北农科技集团股份有限 公司关于召开 2025 年第三次临时股东大会的通知》（以下简称"《召开股东大 会通知》"）以及本所律师认为必要的其他文件和资料 ...

Group 1 - The pork concept sector experienced a decline of 1.11%, ranking among the top declines in concept sectors, with major companies like Juxing Agriculture and He Feng Co. seeing significant drops [1][2] - Among the pork concept stocks, only two companies, Guangming Meat and Delisi, saw price increases of 1.70% and 0.21% respectively [1][2] - The pork concept sector faced a net outflow of 269 million yuan from main funds, with 24 stocks experiencing outflows, and 14 stocks seeing outflows exceeding 10 million yuan [2] Group 2 - The largest net outflow was from Dabeinong, with 55.19 million yuan, followed by New Hope and New Wufeng with outflows of 48.85 million yuan and 23.22 million yuan respectively [2][3] - Conversely, the stocks with the highest net inflow included Muyuan Foods, Guangming Meat, and Delisi, with inflows of 78.63 million yuan, 6.23 million yuan, and 1.95 million yuan respectively [2][3] - The trading volume for Dabeinong was 1.95%, while Guangming Meat had a trading volume of 1.39% [3]

Group 1 - The pork concept sector increased by 2.16%, ranking 7th among concept sectors, with 29 stocks rising, including Zhenghong Technology, which hit the daily limit, and Shennong Group, Dayu Biological, and Muyuan Foods, which rose by 7.70%, 5.06%, and 4.79% respectively [1] - The pork concept sector saw a net inflow of 251 million yuan, with 23 stocks receiving net inflows, and 12 stocks exceeding 10 million yuan in net inflow, led by New Hope with a net inflow of 54.25 million yuan [2][3] - The top stocks by net inflow ratio included Zhenghong Technology, New Five Farms, and Tianbang Foods, with net inflow ratios of 29.78%, 12.94%, and 12.65% respectively [3][4] Group 2 - The top gainers in the pork concept sector included Zhenghong Technology, which rose by 9.96%, and Shennong Group, which rose by 7.70%, while the biggest losers were Bright Food, which fell by 1.91%, and Jingji Zhino, which fell by 1.14% [1][5] - The trading volume and turnover rates for key stocks in the pork sector showed significant activity, with Zhenghong Technology having a turnover rate of 9.04% and New Hope at 1.38% [3][4] - The overall performance of the pork sector reflects a positive sentiment among investors, as indicated by the substantial net inflows and rising stock prices [2][3]

Investment Rating - Industry rating is maintained at "Outperform the Market" [8] Core Viewpoints - The report emphasizes the importance of "self-controllable seed sources" in the context of ongoing US-China trade negotiations, particularly focusing on agricultural imports such as soybeans, corn, and wheat [4][3] - The gap in corn yield between China and the US is widening, which may accelerate the domestic biotechnology breeding industry [5] - The transition of genetically modified organisms (GMOs) into large-scale demonstration phases is highlighted, with significant policy support for the industrialization of biological breeding [6] Summary by Sections Trade and Agricultural Imports - In 2024, China is projected to import 22.13 million tons of soybeans, 2.07 million tons of corn, and 1.90 million tons of wheat from the US, accounting for 44.1%, 3.6%, and 9.0% of US exports respectively [4] - The report suggests that grain trade will be a critical area in the short term for negotiations with the US [4] Yield Disparity and Biotechnology - The US corn yield has reached 766 kg/mu by 2024, with a GMO penetration rate exceeding 90%, while China's corn yield is only 439 kg/mu, resulting in a yield gap of 327 kg/mu [5] - The report identifies the promotion of biotechnology breeding as a key factor contributing to this yield disparity [5] Policy and Market Developments - The central government's focus on biological breeding has been consistent for five years, shifting from research to application, with plans to accelerate the industrialization of biological breeding from 2024 to 2035 [6] - By 2024, GMO grain industrialization will transition from a trial phase to large-scale demonstration in eight provinces, with further expansion planned by 2025 [6] Investment Recommendations - The report recommends investing in leading companies in the biotechnology sector, including Longping High-Tech, Dabeinong, and Quanyin High-Tech, while also suggesting to pay attention to Fengle Seed Industry and Denghai Seed Industry [6]

Investment Rating - Industry rating is maintained at "Outperform the Market" [8] Core Insights - The report emphasizes the importance of "self-controllable seed sources" in the context of ongoing US-China trade negotiations, particularly focusing on agricultural imports such as soybeans, corn, and wheat [4][3] - The gap in corn yield between China and the US is widening, which may accelerate the domestic biotechnology breeding industry [5] - The transition of genetically modified organisms (GMOs) into large-scale demonstration phases is highlighted, with significant policy support for the industrialization of biological breeding [6] Summary by Sections Trade and Agricultural Imports - In 2024, China is projected to import 22.13 million tons of soybeans, 2.07 million tons of corn, and 1.90 million tons of wheat from the US, accounting for 44.1%, 3.6%, and 9.0% of US exports respectively [4] - Short-term agricultural trade is expected to be a key area in US-China negotiations [4] Domestic Yield and Biotechnology - The yield of corn in the US is expected to reach 766 kg/mu by 2024, while China's yield is only 439 kg/mu, resulting in a yield gap of 327 kg/mu [5] - The report identifies the promotion of biotechnology breeding as a critical factor contributing to the widening yield gap [5] Policy and Market Developments - The central government's focus on the industrialization of biological breeding has been consistent for five years, with a shift from research to application [6] - By 2024, the domestic GMO grain industry will transition from a trial phase to large-scale demonstration, with several provinces allowing GMO planting [6] - The report recommends key companies such as Longping High-Tech, Dabeinong, and Quanyin High-Tech for investment, highlighting their competitive advantages in the GMO sector [6]

Core Viewpoint - The animal vaccine sector has shown a positive performance with a 1.29% increase, ranking 10th among concept sectors, driven by significant gains in stocks like *ST Xianfeng, Kexing Pharmaceutical, and Jinhai Biological [1][2]. Group 1: Sector Performance - As of June 10, the animal vaccine concept saw 16 stocks rise, with *ST Xianfeng hitting the daily limit, while Kexing Pharmaceutical and Jinhai Biological increased by 6.40% and 4.72% respectively [1]. - The sector's performance is part of a broader market trend, with various other concepts also experiencing fluctuations, such as the transgenic sector rising by 3.15% [2]. Group 2: Capital Flow - The animal vaccine sector attracted a net inflow of 150 million yuan, with 10 stocks receiving significant capital inflows, and 7 stocks exceeding 10 million yuan in net inflow [2]. - Jinhai Biological led the net inflow with 67.34 million yuan, followed by Kexing Pharmaceutical and Dabeinong with 36.46 million yuan and 21.42 million yuan respectively [2][3]. Group 3: Stock-Specific Data - The top stocks by net capital inflow ratio included *ST Xianfeng at 10.73%, Kexing Pharmaceutical at 9.86%, and Jinhai Biological at 8.93% [3]. - The trading volume and turnover rates for key stocks indicate active trading, with Jinhai Biological showing a turnover rate of 15.46% and Kexing Pharmaceutical at 3.35% [3].

证券代码：002385 证券简称：大北农 公告编号：2025-056 北京大北农科技集团股份有限公司及控股子公司对外担保总额超过最近一 期经审计净资产的 100%，担保金额超过公司最近一期经审计净资产的 50%，本 次公司及控股子公司担保进展中涉及对资产负债率超过 70%的被担保对象"北 京右信供应链管理有限公司、北京易富农商贸发展有限公司、南宁大北农饲料科 技有限责任公司、北京大北农贸易有限责任公司、北京科高大北农生物科技有限 公司、广州易富农商贸发展有限公司、清远大北农生物科技有限公司、四川大北 农农牧科技有限责任公司、天津大北农生物科技有限公司、福建大北农华有水产 科技集团有限公司、江西大北农科技有限责任公司、淮安市淮阴大北农饲料有限 公司、江西高安大北农饲料有限公司、广州大北农农牧科技有限责任公司、宜宾 大北农农牧科技有限公司、四川驰阳农业开发有限公司、湖南大北农华有水产科 技有限公司、昆明云中美农牧科技有限公司、兆丰华生物科技（北京）有限公司、 黑龙江省金色北农种业科技有限公司"提供担保，公司对上述被担保对象在经营 管理、财务、投资、融资等方面均能有效控制，财务风险处于公司有效的控制范 围内，敬请投 ...

Group 1 - The core viewpoint of the announcement is the sales performance of the company's pig farming operations in May 2025, showing significant growth in both sales volume and revenue compared to previous months and the same period last year [2][5]. Group 2 - In May 2025, the total pig sales volume for the company and its subsidiaries reached 727,600 heads, with a total sales revenue of 1.248 billion yuan. Cumulative sales from January to May amounted to 3.1686 million heads and 5.003 billion yuan respectively [2][3]. - The sales volume for the controlling company in May was 386,300 heads, generating a revenue of 623 million yuan, reflecting a month-on-month increase of 15.14% in sales volume and 19.35% in revenue, as well as a year-on-year increase of 17.99% and 16.45% respectively [2][3]. - The sales volume for the affiliated companies in May was 341,300 heads, with a revenue of 625 million yuan, showing a month-on-month increase of 28.50% in sales volume and 28.07% in revenue, along with a year-on-year increase of 77.58% and 69.38% respectively [2][3]. Group 3 - The increase in sales volume and revenue in May 2025 is attributed to changes in the domestic pig market and the gradual release of production capacity [5].

Group 1 - Baiyunshan received drug registration certificate for Tadalafil tablets (2.5mg, 5mg) from the National Medical Products Administration, indicating its entry into the erectile dysfunction treatment market [1] - Huayin Power plans to invest approximately 1.398 billion yuan in three renewable energy projects with a total installed capacity of 230 MW [2] - GAC Group reported a 24.8% year-on-year decline in May automobile sales, with total sales of 117,700 units [3] Group 2 - Honghui Fruits and Vegetables announced a potential change in control due to share transfer negotiations, leading to a temporary suspension of its stock and convertible bonds [4] - Fuyuan Pharmaceutical's subsidiary received a drug registration certificate for Bromhexine Hydrochloride oral solution, aimed at treating respiratory diseases [5][6] - Jianghan New Materials plans to repurchase shares worth 200 million to 400 million yuan, with a maximum price of 30 yuan per share [7][8] Group 3 - Sinan Navigation received an administrative regulatory decision from the Shanghai Securities Regulatory Bureau due to multiple issues in its 2024 annual report [9][10] - Hesheng Co. received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [11] - Daqin Railway reported a 1.85% year-on-year decrease in cargo transportation volume in May, totaling 32.96 million tons [13] Group 4 - Ningbo Construction's subsidiary won a design and construction project with a bid of 787 million yuan [14] - Yuehongyuan A announced the termination of a major asset restructuring plan due to failure to reach an agreement on key terms [15][16] - Mingyang Smart Energy reached a 190 million yuan repurchase agreement with Haiji New Energy [18] Group 5 - CNE Group's subsidiary plans to reduce registered capital from 430 million yuan to 330 million yuan [19] - ST Baili received an administrative penalty for failing to disclose non-operating fund occupation matters, resulting in a fine of 4 million yuan [21] - Baichuan Co. completed the repurchase of a 7.14% stake in its subsidiary for 50 million yuan [22] Group 6 - Dongrui Co. reported May sales of 155,400 pigs, generating revenue of 203 million yuan, a decrease of 8.77% month-on-month [25][26] - Pengding Holdings reported a 22.43% year-on-year increase in May consolidated revenue, totaling 2.598 billion yuan [27] - Dabeinong reported May sales of 727,600 pigs, with total revenue of 1.248 billion yuan [28] Group 7 - Lihua Co. reported a 4.77% year-on-year decrease in May chicken sales revenue, totaling 1.118 billion yuan [29][30] - Jindan Technology plans to use up to 300 million yuan of idle funds for entrusted wealth management [31] - Youxunda won a project from the State Grid worth approximately 176 million yuan [33][34] Group 8 - Shenglan Co. received approval for its convertible bond issuance from the Shenzhen Stock Exchange [35][36] - Jingfang Technology's shareholder plans to reduce holdings by up to 2% of the company's shares [37] - Shiji Information's subsidiary signed a significant contract with Marriott for cloud services [39] Group 9 - Northeast Securities' subsidiary plans to terminate its listing on the New Third Board [40] - Yaji International's supervisor is under investigation for insider trading [42][43] - Yian Technology signed a strategic cooperation framework agreement with Shenzhen Hive Interconnect Technology [44] Group 10 - Jinyu Group's subsidiary acquired a real estate project for 3.364 billion yuan [46][47] - Kaiweite's major shareholder plans to reduce holdings by up to 3% of the company's shares [48] - Ningbo Energy's subsidiary plans to publicly transfer fixed assets valued at approximately 17.4372 million yuan [49]